Stockscreener 앱 받기
0.96%
전일 마감가:
$116.14
열려 있는:
$115.91
하루 거래량:
3.14M
Relative Volume:
0.41
시가총액:
$142.99B
수익:
$14.88B
순이익/손실:
$6.10B
주가수익비율:
30.02
EPS:
3.8977
순현금흐름:
$869.79M
1주 성능:
-1.06%
1개월 성능:
-2.15%
6개월 성능:
-19.92%
1년 성능:
-15.57%
1일 변동 폭
$115.06
$117.74
1주일 범위
$114.50
$120.33
52주 변동 폭
$101.73
$190.09
블랙스톤 Stock (BX) Company Profile
명칭
Blackstone Inc
전화
(212) 583-5000
주소
345 PARK AVENUE, NEW YORK, NY
Compare BX vs BLK, BN, KKR, BAM
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
BX
Blackstone Inc
|
117.06 | 141.87B | 14.88B | 6.10B | 869.79M | 3.8977 |
BLK
Blackrock Inc
|
1,054.38 | 162.45B | 26.28B | 6.75B | 3.76B | 38.77 |
BN
Brookfield Corp
|
45.75 | 102.92B | 77.61B | 4.06B | -8.36B | 0.497 |
KKR
Kkr Co Inc
|
96.64 | 84.43B | 22.38B | 5.74B | 8.54B | 2.9339 |
BAM
Brookfield Asset Management Ltd
|
48.81 | 78.26B | 5.07B | 2.48B | 2.37B | 1.5532 |
블랙스톤 Stock (BX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-04-13 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2026-03-05 | 재개 | Barclays | Equal Weight |
| 2026-02-24 | 개시 | RBC Capital Mkts | Outperform |
| 2025-12-11 | 재개 | UBS | Neutral |
| 2025-10-03 | 개시 | BMO Capital Markets | Outperform |
| 2025-04-08 | 업그레이드 | Citizens JMP | Mkt Perform → Mkt Outperform |
| 2025-03-17 | 업그레이드 | UBS | Neutral → Buy |
| 2024-12-12 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2024-12-09 | 업그레이드 | TD Cowen | Hold → Buy |
| 2024-10-09 | 다운그레이드 | Piper Sandler | Overweight → Neutral |
| 2024-09-12 | 개시 | Wells Fargo | Overweight |
| 2024-08-27 | 개시 | Redburn Atlantic | Neutral |
| 2024-04-02 | 다운그레이드 | UBS | Buy → Neutral |
| 2024-01-19 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2024-01-11 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2024-01-04 | 개시 | TD Cowen | Market Perform |
| 2024-01-03 | 다운그레이드 | Goldman | Buy → Neutral |
| 2023-12-20 | 재개 | Piper Sandler | Overweight |
| 2023-12-06 | 재개 | BMO Capital Markets | Market Perform |
| 2023-10-06 | 개시 | HSBC Securities | Hold |
| 2023-10-05 | 개시 | Wolfe Research | Peer Perform |
| 2023-07-21 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2023-05-19 | 개시 | Citigroup | Buy |
| 2023-04-13 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2023-01-24 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2023-01-11 | 업그레이드 | Wells Fargo | Equal Weight → Overweight |
| 2022-12-02 | 다운그레이드 | Barclays | Overweight → Equal Weight |
| 2022-11-22 | 다운그레이드 | Credit Suisse | Neutral → Underperform |
| 2022-10-19 | 개시 | Credit Suisse | Neutral |
| 2022-10-11 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-08-31 | 개시 | Barclays | Overweight |
| 2022-07-25 | 다운그레이드 | Keefe Bruyette | Outperform → Mkt Perform |
| 2022-04-07 | 다운그레이드 | Exane BNP Paribas | Outperform → Neutral |
| 2021-12-16 | 재개 | BofA Securities | Buy |
| 2021-12-16 | 개시 | Wells Fargo | Equal Weight |
| 2021-11-04 | 재개 | BofA Securities | Buy |
| 2021-08-11 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2021-03-19 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-01-14 | 개시 | Piper Sandler | Overweight |
| 2020-10-29 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2020-06-25 | 개시 | UBS | Buy |
| 2020-06-08 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-10-14 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2019-10-08 | 개시 | BMO Capital Markets | Market Perform |
| 2019-10-01 | 개시 | Wells Fargo | Outperform |
| 2019-09-24 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2019-09-23 | 재확인 | BofA/Merrill | Buy |
| 2019-09-18 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2019-08-05 | 개시 | Barclays | Overweight |
| 2019-07-08 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-01-12 | 업그레이드 | JP Morgan | Neutral → Overweight |
| 2017-05-22 | 업그레이드 | Citigroup | Neutral → Buy |
| 2016-03-11 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2016-02-02 | 재확인 | Argus | Buy |
| 2016-01-26 | 재확인 | RBC Capital Mkts | Outperform |
| 2016-01-08 | 재확인 | Deutsche Bank | Buy |
| 2015-12-08 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2015-11-23 | 개시 | JP Morgan | Neutral |
| 2015-10-27 | 재확인 | Argus | Buy |
모두보기
블랙스톤 주식(BX)의 최신 뉴스
Apollo, Blackstone arrange $36B debt deal for Anthropic AI chips - qz.com
CPP Investments Sells C$4B PE Portfolio to Blackstone, Ardian - connectmoney.com
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund Grows Stake in Blackstone Inc. $BX - MarketBeat
69,000 Shares in Blackstone Inc. $BX Acquired by Ilmarinen Mutual Pension Insurance Co - MarketBeat
HSG said to be in lead to buy Blackstone-backed Leica Camera - The Edge Singapore
HSG Is Said to Be in Lead to Buy Blackstone-Backed Leica Camera - Bloomberg.com
Apollo, Blackstone work on $36 billion debt deal for Anthropic - Communications Today
Blackstone (BX) to Invest $5B in TPU Cloud Joint Venture with Google - Yahoo Finance
Apollo, Blackstone shop $36b AI deal for Anthropic - Tech in Asia
Blackstone’s Stephen Schwarzman Boosts Micron Technology Stake 13,503 Shares - TipRanks
Apollo, Blackstone work on $36 billion debt deal for Anthropic: Report - The Economic Times
Blackstone’s VFS banks mega profits on African, Asian visa applicants - Semafor
Asset Managers Profiting From the Alternatives Boom - Kalkine Media
Apollo Global Management (APO) and Blackstone (BX) Lead $36B Deb - GuruFocus
Blackstone (BX) Partners in $36B Debt Financing for Anthropic's AI Development - GuruFocus
Blackstone Inc (BX) Stock Price, Trades & News - GuruFocus
Apollo, Blackstone work on $36 billion debt deal for Anthropic, Bloomberg News reports - Reuters
Apollo and Blackstone ready record $36 billion loan to power Anthropic’s AI push - Investing.com Australia
Apollo Shops $36 Billion Debt Deal to Buy Google Chips for Anthropic - Bloomberg.com
Medline closes secondary offering of 72.6 million shares at $37 By Investing.com - Investing.com Canada
Medline Inc. announces closing of upsized secondary offering of Class A common stock - The Manila Times
Blackstone to Present at Morgan Stanley’s US Financials Conference - The Joplin Globe
UBS AG (AMUB) issues $400K Trigger Autocallable Notes tied to Blackstone stock - Stock Titan
Blackstone Swings Put S&P 500 Valuation In Focus - Kalkine Media
Is It Time To Reassess Blackstone (BX) After Recent Price Swings? - simplywall.st
Apogee Therapeutics: $1.3 Billion Blackstone Financing To Advance Zumilokibart Phase 3 Development - Pulse 2.0
Apogee secures $1.3bn Blackstone deal to advance eczema drug - BioXconomy
Blackstone bets up to 1.3 billion on Apogee Therapeutics - Il Sole 24 ORE
Ranch products recalled from Walmart in ongoing salmonella issue - Greenville Online
Blackstone Products is recalling its Parmesan Ranch seasoning sold at Walmart over salmonella fears - qz.com
Foundations Investment Advisors LLC Buys 21,913 Shares of Blackstone Inc. $BX - MarketBeat
Geode Capital Management LLC Decreases Stock Position in Blackstone Inc. $BX - MarketBeat
Key facts: Blackstone to fund Apogee $1.3B; backs Ksi Lisims - TradingView
Apogee Therapeutics Soars After $1.3B Deal with Blackstone Life Sciences - StockInvest.us
Inside Blackstone: Stephen A. Schwarzman on long-term investing across cycles - Livewire Markets
Blackstone closes in on HSBC’s $26bn mortgage book - The Australian
Apogee’s Royalty Deal With Blackstone Will Fund Pivotal Test in Eczema and More - MedCity News
Apogee Doubles Its Cash Position As It Reports New Phase II Zumilokibart Data - Citeline News & Insights
Young biotech Apogee lands $1.3B deal that is called 'largest royalty financing' of its kind - The Business Journals
Apogee secures up to $1.3 billion from Blackstone to advance eczema drug - Reuters
Ranch products recalled from NC Walmarts in ongoing salmonella issue - The Asheville Citizen Times
Blackstone Backs Apogee With Up To $1.3 Billion - TradingView
Waltham Biotech Company Gets Big Financial Boost To Develop Eczema Drug: Report - Patch
Blackstone Inc. stock: Why its latest portfolio moves matter - AD HOC NEWS
Recall alert: Blackstone seasoning sold at Walmart recalled for possible Salmonella - WSB-TV
12 Most Profitable Stocks to Invest In - Insider Monkey
FDA Recalls Walmart Blackstone Parmesan Ranch Nationwide Warning Over Possible Salmonella Contamination - Nbsla.ca
Blackstone Life Sciences commits up to $1.3B to fund Waltham biotech's drug - The Business Journals
Apogee Therapeutics, Inc. announced that it expects to receive $500 million in funding - marketscreener.com
Ranch Seasoning Recalled for Potential Salmonella Contamination - People.com
New CLOs at Blackstone, Guggenheim Boast Key Perk: Less Software - Bloomberg.com
블랙스톤 (BX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.23%
자본화:
|
볼륨(24시간):